Opaleye Management Inc. Quant / Systematic

Location: Boston, MA

CIK: 0001595855 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value: $393M (100.0% shares, 0.0% debt)

Holdings (47)

AXGN AXOGEN INC 12.2%
Value $47.91M Shares 1,300,000 Est. Cost $3.33 Unrealized +1212.4%
CDXS CODEXIS INC 7.6%
Value $30.01M Shares 1,750,000 Est. Cost $3.21 Unrealized +403.0%
LOXO ONCOLOGY 7.6%
Value $29.89M Shares 175,000 Est. Cost $43.63 Unrealized
AMARIN CORP PLC 6.6%
Value $26.03M Shares 1,600,000 Est. Cost $3.50 Unrealized
BLUEPRINT MEDICINES 6.0%
Value $23.42M Shares 300,000 Est. Cost $27.77 Unrealized
DECIPHERA PHARMACEUTICALS IN 4.1%
Value $16.26M Shares 420,000 Est. Cost $22.57 Unrealized
POLARITYTE INC 3.7%
Value $14.61M Shares 765,000 Est. Cost $23.54 Unrealized
VKTX VIKING THERAPEUTICS INC 3.7%
Value $14.37M Shares 825,000 Est. Cost $4.57 Unrealized +160.3%
FIBROGEN INC 3.1%
Value $12.15M Shares 200,000 Est. Cost $26.18 Unrealized
AGIO AGIOS PHARMACEUTICALS 2.6%
Value $10.03M Shares 130,000 Est. Cost $43.03 Unrealized +87.0%
AUDENTES THERAPEUTICS INC 2.3%
Value $8.907M Shares 225,000 Est. Cost $24.89 Unrealized
MAGENTA THERAPEUTICS INC 2.2%
Value $8.707M Shares 725,000 Est. Cost $13.14 Unrealized
PTCT PTC THERAPEUTICS INC 2.2%
Value $8.46M Shares 180,000 Est. Cost $26.47 Unrealized +56.3%
AMAG PHARMACEUTICALS INC 2.1%
Value $8.4M Shares 420,000 Est. Cost $19.50 Unrealized
STRONGBRIDGE BIOPHARMA PLC 2.1%
Value $8.39M Shares 1,730,000 Est. Cost $4.28 Unrealized
SGMO SANGAMO BIOSCIENCES INC 2.1%
Value $8.305M Shares 490,000 Est. Cost $3.76 Unrealized +304.6%
FENC FENNEC PHARMACEUTICALS INC 2.0%
Value $7.995M Shares 975,000 Est. Cost $10.08 Unrealized -8.0%
MIRAGEN THERAPEUTICS INC 2.0%
Value $7.788M Shares 1,395,700 Est. Cost $6.29 Unrealized
CYMABAY THERAPEUTICS INC 2.0%
Value $7.735M Shares 698,100 Est. Cost $8.30 Unrealized
XENE XENON PHARMACEUTICALS INC 1.8%
Value $7.014M Shares 465,200 Est. Cost $11.59 Unrealized 0.0%
APLS APELLIS PHARMACEUTICALS INC 1.7%
Value $6.667M Shares 375,000 Est. Cost $21.66 Unrealized -14.7%
XNCR XENCOR INC 1.6%
Value $6.14M Shares 180,000 Est. Cost $34.46 Unrealized +18.3%
RARE ULTRAGENYX PHARMACEUTICALS INC 1.6%
Value $6.107M Shares 80,000 Est. Cost $49.03 Unrealized +65.9%
XOMA XOMA CORP DEL 1.4%
Value $5.622M Shares 320,000 Est. Cost $6.46 Unrealized +210.4%
OCUL OCULAR THERAPEUTIX INC 1.4%
Value $5.504M Shares 800,000 Est. Cost $6.87 Unrealized -8.7%
CIDARA THERAPEUTICS INC 1.3%
Value $5.28M Shares 1,200,000 Est. Cost $5.20 Unrealized
CORIUM INTERNATIONAL INC 1.3%
Value $5.23M Shares 550,000 Est. Cost $8.50 Unrealized
CHIMERIX INC 1.2%
Value $4.609M Shares 1,185,000 Est. Cost $4.89 Unrealized
IMPRIMIS PHARMACEUTICALS 1.1%
Value $4.503M Shares 1,620,000 Est. Cost $2.78 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 1.0%
Value $4.048M Shares 195,000 Est. Cost $15.73 Unrealized 0.0%
IOVA IOVANCE BIOTHERAPEUTICS INC 0.9%
Value $3.656M Shares 325,000 Est. Cost $14.19 Unrealized 0.0%
CTI BIOPHARMA CORP 0.9%
Value $3.348M Shares 1,550,000 Est. Cost $2.45 Unrealized
CARA THERAPEUTICS INC 0.8%
Value $3.113M Shares 130,000 Est. Cost $23.95 Unrealized
ARQULE INC 0.8%
Value $3.113M Shares 550,000 Est. Cost $5.56 Unrealized
CLLS CELLECTIS SA 0.8%
Value $3.104M Shares 110,000 Est. Cost $28.22 Unrealized
ARDX ARDELYX INC 0.7%
Value $2.827M Shares 650,000 Est. Cost $4.16 Unrealized 0.0%
EPIZYME INC 0.5%
Value $2.12M Shares 200,000 Est. Cost $14.62 Unrealized
TGTX TG THERAPEUTICS INC 0.5%
Value $1.96M Shares 350,000 Est. Cost $13.33 Unrealized -14.3%
PROTALIX BIOTHERAPEUTICS INC 0.5%
Value $1.817M Shares 2,500,000 Est. Cost $0.61 Unrealized
CLEMENTIA PHARMACEUTICAL INC 0.4%
Value $1.66M Shares 148,832 Est. Cost $11.15 Unrealized
TRICIDA INC 0.4%
Value $1.558M Shares 51,000 Est. Cost $30.55 Unrealized
BIOFRONTERA AG 0.3%
Value $1.073M Shares 79,007 Est. Cost $12.15 Unrealized
DERMIRA INC 0.3%
Value $1.061M Shares 97,400 Est. Cost $10.89 Unrealized
ACHILLION PHARMACEUTICALS INC 0.3%
Value $1.012M Shares 275,000 Est. Cost $3.68 Unrealized
INFIQ INFINITY PHARMACEUTICALS INC 0.2%
Value $745K Shares 275,000 Est. Cost $2.07 Unrealized 0.0%
FOAMIX LTD 0.1%
Value $521K Shares 91,000 Est. Cost $5.96 Unrealized
BIOLINERX LTD 0.1%
Value $267K Shares 250,000 Est. Cost $1426.15 Unrealized